LASA.NS
Lasa Supergenerics Ltd
Price:  
16.80 
INR
Volume:  
18,395.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LASA.NS WACC - Weighted Average Cost of Capital

The WACC of Lasa Supergenerics Ltd (LASA.NS) is 14.1%.

The Cost of Equity of Lasa Supergenerics Ltd (LASA.NS) is 16.30%.
The Cost of Debt of Lasa Supergenerics Ltd (LASA.NS) is 7.00%.

Range Selected
Cost of equity 13.40% - 19.20% 16.30%
Tax rate 13.50% - 17.30% 15.40%
Cost of debt 7.00% - 7.00% 7.00%
WACC 11.9% - 16.4% 14.1%
WACC

LASA.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 0.79 1.22
Additional risk adjustments 0.0% 0.5%
Cost of equity 13.40% 19.20%
Tax rate 13.50% 17.30%
Debt/Equity ratio 0.26 0.26
Cost of debt 7.00% 7.00%
After-tax WACC 11.9% 16.4%
Selected WACC 14.1%

LASA.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for LASA.NS:

cost_of_equity (16.30%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.79) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.